GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Navidea Biopharmaceuticals Inc. (NAVB) [hlAlert]

Neoprobe Corporation (Neoprobe) is a biomedical company that develops and commercializes products that enhance patient care and improve patient outcome by meeting the intraoperative diagnostic information needs of physicians
and therapeutic treatment needs of patients. The Company markets two lines of medical devices, which includes its neoprobe GDS gamma detection systems and the Quantix line of blood flow measurement devices of its subsidiary, Cardiosonix Ltd. In addition to its medical device products, it has two radiopharmaceutical products, Lymphoseek and RIGScan CR, in advanced phases of clinical development.
.
( Total: 8 Current Stock Recommendations )
Navidea Biopharmaceuticals Inc.   (8)
Sell Hold 25% Buy 62%
Related companies
Filter by Gains:   
  
Rating:
Hold NAVB

Rating:
Buy NAVB
down 31.81 %

Rating:
Sell NAVB
up 73.33 %
Neoprobe Corp. (NAVB) rated Underweight by Piper Jaffray
Wednesday,  Mar 6, 2013  8:25 AM ET

Rating:
Buy NAVB
down 39.79 %

Rating:
Hold NAVB

Rating:
Buy NAVB
3 Months Gains
down 30.76 %

Rating:
Hold NAVB
Neoprobe Corp. (NAVB) rated Hold by ThinkEquity
Tuesday,  Sep 11, 2012  8:25 AM ET

Rating:
Buy NAVB
down 31.81 %

Rating:
Buy NAVB
down 48.12 %

Rating:
Buy NAVB
down 62.18 %

Rating:
Buy NAVB
3 Months Gains
down 60.69 %

Rating:
Buy NAVB
down 48.12 %

Rating:
Buy NAVB

Your Recent Stocks
SymbolLastChange
NAVB 1.80 up  1.12 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy